Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.46 |
| ▸ | GGT1 | P19440 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 2/20 | 0.44 |
| ▸ | CPA3 | P15088 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14935818 | 1.00 | FOLH1 (0.46) | FOLH1GGT1GAAMAPTPOLB | |
| SCHEMBL7270248 | 1.00 | FOLH1 (0.46) | FOLH1GGT1GAAMAPTPOLB | |
| Benzenemethanethiol SCHEMBL11583112 | 0.95 | POLB (0.44) | FOLH1GGT1GAAMAPTPOLB | |
| SCHEMBL1109641 | 0.86 | CPA3 (0.50) | FOLH1GAAMAPTPOLBMME | |
| SCHEMBL515921 | 0.86 | CPA3 (0.50) | FOLH1GAAMAPTPOLBMME | |
| SCHEMBL1031027 | 0.86 | CPA3 (0.50) | FOLH1GAAMAPTPOLBMME | |
| SCHEMBL31425145 | 0.85 | ALDH1A1 (0.48) | FOLH1POLB | |
| SCHEMBL6051729 | 0.85 | SMN1; SMN2 (0.45) | — | |
| SCHEMBL10482542 | 0.84 | MME (0.56) | GGT1GAAMAPTPOLBMME | |
| SCHEMBL21274596 | 0.84 | GGT1 (0.47) | GGT1GAAMAPTPOLBTLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9718921-B2 | Amphiphilic derivatives of thioether containing block copolypeptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-08-01 | — | — | US | claimed |
| US-20160002405-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | NATIONAL SCIENCE FOUNDATION | 2016-01-07 | — | — | US | claimed |
| EP-2961758-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | The Regents of The University of California (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150057433-A1 | PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-02-26 | — | — | US | claimed |
| EP-2831090-A1 | PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS | The Regents of The University of California (US) | 2015-02-04 | — | — | EP | claimed |
| WO-2014134203-A9 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-23 | — | — | WO | claimed |
| WO-2014134203-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-04 | — | — | WO | claimed |
| WO-2013148727-A1 | PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-10-03 | — | — | WO | claimed |
| US-20250367300-A1 | Nanomaterial and Methods of Use Thereof | UNIVERSITY OF CONNECTICUT (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250302971-A1 | Therapeutic Nanomaterials | UNIV CONNECTICUT (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250302762-A1 | NANOMATERIAL DELIVERY VEHICLE AND METHOD OF USE THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250229081-A1 | NANOMATERIAL COATED ELECTRODE AND METHODS OF USE THEREOF | UNIVERSITY OF CONNECTICUT | 2025-07-17 | — | — | US | disclosed |
| CN-120202010-A | Ligand-oligonucleotide conjugates and linkers for use therewith | 上海京新生物医药有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-20250084410-A1 | INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF | Synthorx, Inc. (US) | 2025-03-13 | — | — | US | disclosed |
| EP-1123919-A1 | PROCESS FOR PRODUCING PEPTIDYL ALDEHYDES | Senju Pharmaceutical Co., Ltd. (JP) | 2001-08-16 | — | — | EP | disclosed |
| CN-1030616-C | Process for producing L-lysins by fermentation | AJINOMOTO KK (JP) | 1996-01-03 | — | — | CN | disclosed |
| CN-1045419-A | The method of fermentation production of L-lysine | AJINOMOTO KK (JP) | 1990-09-19 | — | — | CN | disclosed |
| US-4477441-A | HYPOTENSIVE AGENTS | MERCK & CO., INC. (US) | 1984-10-16 | — | — | US | disclosed |
| US-4477440-A | HYPERTENSIVE AGENTS; HYPERALDOSTERONISM; MEDICAL DIAGNOSIS; CYCLIC POLYPEPTIDES | MERCK & CO., INC. (US) | 1984-10-16 | — | — | US | disclosed |
| US-4153729-A | ANTILIPEMIC AGENTS | RECHERCHES PHARMACEUTIQUES ET SCIENTIFIQUES (FR) | 1979-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302971-A1 | Therapeutic Nanomaterials | TIE1, TEKT1, POLRMT | FOLH1 1650/4885GGT1 2996/4885GAA 3358/4885 |
| US-20250367300-A1 | Nanomaterial and Methods of Use Thereof | EPCAM, CD47, JAK2 | FOLH1 2480/4885GGT1 2054/4885GAA 2661/4885 |
| US-20250302762-A1 | NANOMATERIAL DELIVERY VEHICLE AND METHOD OF USE THEREOF | JAK2, JAK1, CHMP4B | FOLH1 1458/4885GGT1 4387/4885GAA 3593/4885 |
| US-20150057433-A1 | PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS | PTMS, TMT1A, PTMA | FOLH1 374/4885GGT1 317/4885GAA 3544/4885 |
| US-20250084410-A1 | INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF | RNGTT, TRMT1, OSGEP | FOLH1 662/4885GGT1 713/4885GAA 850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.